XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.26.1

EQUITY-BASED COMPENSATION PLANS | 6 Months Ended
--- | ---
Jun. 28, 2026
Share-Based Payment Arrangement [Abstract] |
EQUITY-BASED COMPENSATION PLANS | EQUITY-BASED COMPENSATION PLANS In 2021, the Company adopted the 2021 Omnibus Incentive Plan (the “2021 Plan”), under which awards, including stock options, restricted stock units ("RSUs") and performance stock units ("PSUs") may be granted to employees and non-employee directors. The 2021 Plan authorized 8,850,000 shares of Common Stock to be available for award grants. On May 1, 2026, the stockholders of the Company approved an amendment to the 2021 Plan to increase the number of authorized shares of Common Stock reserved for delivery under the Plan by 5,000,000 shares of Common Stock, thereby increasing the shares of Common Stock reserved under the amended plan to 13,850,000. On May 6, 2026, the Company filed a registration statement on Form S-8 to register an additional 5,000,000 shares of Common Stock issuable under the 2021 Plan. As of June 28, 2026, 5,932,562 shares of Common Stock remained available for future issuance under the 2021 Plan. Equity-based compensation expense included the following components:
| For the thirteen weeks ended |  | For the twenty-six weeks ended
| June 28, 2026 |  | June 29, 2025 |  | June 28, 2026 |  | June 29, 2025
Restricted stock units | $ | 1,222 |  |  | $ | 1,017 |  |  | $ | 2,512 |  |  | $ | 1,976 |
Performance stock units | 343 |  |  | 386 |  |  | 784 |  |  | 878 |
Stock options | — |  |  | 5 |  |  | — |  |  | 49 |
All equity-based compensation expenses are recorded in selling, general and administrative costs in the condensed consolidated statements of comprehensive income. Restricted Stock Awards RSUs and PSUs are collectively referred to as "Restricted Stock Awards". The Compensation Committee has awarded RSUs to select employees and non-employee directors and has awarded PSUs to select employees. The RSUs vest ratably over one to four years of continued employment or board services, as applicable. The grant date fair value of a time-based award or a performance-based award without a market condition is equal to the market price of Common Stock on the grant date and is recognized over the requisite service period. The grant date fair value of a performance-based award with a market condition is determined using a Monte Carlo simulation and is recognized over the requisite service period. On June 28, 2026, there was $9,612 of unrecognized compensation cost related to unvested Restricted Stock Awards that is expected to be recognized over a remaining weighted average period of 1.8 years. The weighted-average grant-date fair value of Restricted Stock Awards granted during the 26-week periods ended June 28, 2026 and June 29, 2025, was $3.06 a nd $2.57, respectively. The fair value of Restricted Stock Awards vested and converted to shares of Common Stock during the 26-week periods ended June 28, 2026 and June 29, 2025, was $4,470 and $1,084, re spectively. The following table summarizes Restricted Stock Awards for the 26-week period ended June 28, 2026:
| Unvested Restricted Stock Awards
| Number of RSAs |  | Weighted Average Grant Date Fair Value
Balance on December 31, 2025 | 6,385,354 |  | $ | 2.91 |
Granted | 2,068,935 |  | 3.06 |
Vested | (1,580,709) |  | 2.61 |
Forfeited | (683,086) |  | 3.11 |
Balance on June 28, 2026 | 6,190,494 |  | $ | 3.01 |
Performance-based Restricted Stock Units The PSUs granted under the 2021 Plan represent shares of Common Stock that are potentially issuable in the future based on a combination of performance and service requirements. On March 13, 2026 and May 1, 2026, the Company granted 379,211 and 273,532 PSUs, respectively, under the 2021 Plan to employees with a grant date fair values of $3.01 and $3.10, respectively. The PSUs granted to employees were based on salary and include annual net sales and adjusted EBITDA growth targets with threshold and stretch goals. The awards vest ratably over three years, subject to the employee’s continuous employment through the vesting date and the level of performance achieved. The number of PSUs granted reflects the target number able to be earned under a given award. Non-vested PSU compensation expense is based on the most recent performance assumption available and is adjusted as assumptions change. The fair value of a PSU at the grant date is equal to the market price of Common Stock on the grant date. The cost estimates for PSU grants represent initial target awards until the Company can reasonably forecast the financial performance of each PSU award grant. The actual number of shares of Common Stock to be issued at the end of each performance period will range from 0% to 150% of the initial target awards. Stock Options Stock option grants have an exercise price at least equal to the market value of the underlying Common Stock on the date of grant, have ten-year terms, and vest ratably over three years of continued employment. In general, vested options expire if not exercised within 90 days of termination of service. Compensation expense for stock options is recorded based on straight-line amortization of the grant date fair value over the requisite service period. As of June 28, 2026, all stock options were vested and there was no additional compensation cost to recognize. The following table summarizes stock option activity for the 26-week period ended June 28, 2026:
| Number of Stock Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (years)
Options outstanding on December 31, 2025 | 437,268 |  | $ | 10.99 |  |  |
Forfeited | - |  | - |  |  |
Expired | (82,418) |  | - |  |  |
Options outstanding on June 28, 2026 | 354,850 |  | $ | 11.00 |  |  | 5.33
Options exercisable on June 28, 2026 | 354,850 |  | $ | 11.00 |  |  | 5.33

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration